HMPL-523

· Hutchison Medipharma Limited

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for HMPL-523, covering 2016-04-28 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma [Phase 1]

See pricing